A Preclinical Study of an <sup>125</sup>I-Labeled PSMA Ligand for Prostate-Cancer Puncture

A Preclinical Study of an <sup>125</sup>I-Labeled PSMA Ligand for Prostate-Cancer Puncture

Purpose: Prostate cancer (PCa) is characterized by high expression of prostate-specific 1membrane antigen (PSMA), a type II transmembrane protein. Prostate-specific membrane antigen positron emission tomography (PSMA PET) has high sensitivity and specificity and can therefore be potentially used to...

Full description

Bibliographic Details
Main Authors: Xiaohui Luan, Haoxi Zhou, Yimin Chen, Xiaojun Zhang, Mengchao Cui, Kuang Chen, Xiaodan Xu, Jinming Zhang, Baixuan Xu
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Pharmaceuticals
Subjects:
<sup>125</sup>I-PSMA-7
prostate cancer
targeted biopsy
SPECT/CT
Online Access:https://www.mdpi.com/1424-8247/15/10/1252

Internet

https://www.mdpi.com/1424-8247/15/10/1252

Similar Items